YOUR BUSINESS AUTHORITY
Springfield, MO
YOUR BUSINESS AUTHORITY
Springfield, MO
Johnson & Johnson's strong sales of cancer drugs and products in its baby care business helped push third-quarter earnings beyond analysts' expectations.
The company reported adjusted earnings per share of $2.05, 2 cents above forecasts. Revenue was $20.3 billion, beating the $20.05 billion analysts expected.
Third-quarter net income came to $3.9 billion, compared with $3.8 billion a year earlier.
Read more from CNBC.
Trent Overhue says he plans to complete property’s stalled projects.
Billy Long faces scrutiny over recent donations
Curb Appeal: Nearly $4M residence among 27 listings in March
New Plaza Towers owner revives vision for landmark building
KC developer sentenced to prison for fraud
Columbia projected to spend 80% of cash reserves by 2031